Home / Cancer and immune system / Ibrutinib
ATC L01EL01 · Bruton's Tyrosine Kinase (BTK) Inhibitors · updated 2 Nov 2026
Ibrutinib shortage
As of 2 Nov 2026, Ibrutinib has a reported shortage in 1 of the 16 countries we track (Switzerland), covering 1 product from 1 company.
Is there an Ibrutinib shortage?
Yes. As of 2 Nov 2026, Ibrutinib is reported short in 1 of the 16 countries we track: Switzerland. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Johnson & Johnson JNJ · NYSE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | IMBRUVICA Filmtabl 560 mg 28 Stk limited | Janssen-Cilag AG | 20 Jun 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Ibrutinib shortage?
Yes. As of 2 Nov 2026, Ibrutinib is reported short in 1 of the 16 countries we track: Switzerland. No company has given a return date.
When will Ibrutinib be back in stock?
No return date has been given; Switzerland: no date given. These are company estimates reported to each authority.
Why is Ibrutinib in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Ibrutinib shortages?
Johnson & Johnson.